Szmuness W - Search Results

1

A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report.

Szmuness W, Stevens CE, Zang EA, Harley EJ, Kellner A. Szmuness W, et al. Hepatology. 1981 Sep-Oct;1(5):377-85. doi: 10.1002/hep.1840010502. Hepatology. 1981. PMID: 7030902 Clinical Trial.

2

Hepatitis B immune globulin: final report of a controlled, multicenter trial of efficacy in prevention of dialysis-associated hepatitis.

Prince AM, Szmuness W, Mann MK, Vyas GN, Grady GF, Shapiro FL, Suki WN, Freidman EA, Avram MM, Stenzel KH. Prince AM, et al. Among authors: szmuness w. J Infect Dis. 1978 Feb;137(2):131-44. doi: 10.1093/infdis/137.2.131. J Infect Dis. 1978. PMID: 342639 Clinical Trial.

3

Hepatitis B vaccine in medical staff of hemodialysis units: efficacy and subtype cross-protection.

Szmuness W, Stevens CE, Harley EJ, Zang EA, Alter HJ, Taylor PE, DeVera A, Chen GT, Kellner A. Szmuness W, et al. N Engl J Med. 1982 Dec 9;307(24):1481-6. doi: 10.1056/NEJM198212093072403. N Engl J Med. 1982. PMID: 6755247 Clinical Trial.

4

Immune response to hepatitis B vaccine in newborns.

Prozesky OW, Stevens CE, Szmuness W, Rolka H, Harley EJ, Kew MC, Scholtz JE, Mitchell AD. Prozesky OW, et al. Among authors: szmuness w. J Infect. 1983 Jul;7 Suppl 1:53-5. doi: 10.1016/s0163-4453(83)96649-5. J Infect. 1983. PMID: 6674370

5

Efficacy of hepatitis B immune globulin for prevention of perinatal transmission of the hepatitis B virus carrier state: final report of a randomized double-blind, placebo-controlled trial.

Beasley RP, Hwang LY, Stevens CE, Lin CC, Hsieh FJ, Wang KY, Sun TS, Szmuness W. Beasley RP, et al. Among authors: szmuness w. Hepatology. 1983 Mar-Apr;3(2):135-41. doi: 10.1002/hep.1840030201. Hepatology. 1983. PMID: 6339349 Clinical Trial.

6

Immunogenicity of HBV vaccine in healthy Chinese children.

Hwang LY, Beasley RP, Stevens CE, Szmuness W. Hwang LY, et al. Among authors: szmuness w. Vaccine. 1983 Dec;1(1):10-2. doi: 10.1016/0264-410x(83)90005-1. Vaccine. 1983. PMID: 6241767 Clinical Trial.

7

HBIG prophylaxis for perinatal HBV infections--final report of the Taiwan trial.

Beasley RP, Hwang LY, Szmuness W, Stevens CE, Lin CC, Hsieh FJ, Wang KY, Sun TS. Beasley RP, et al. Among authors: szmuness w. Dev Biol Stand. 1983;54:363-75. Dev Biol Stand. 1983. PMID: 6360754 Clinical Trial.

8

Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state. Initial report of a randomised double-blind placebo-controlled trial.

Beasley RP, Hwang LY, Lin CC, Stevens CE, Wang KY, Sun TS, Hsieh FJ, Szmuness W. Beasley RP, et al. Among authors: szmuness w. Lancet. 1981 Aug 22;2(8243):388-93. doi: 10.1016/s0140-6736(81)90832-1. Lancet. 1981. PMID: 6115159 Clinical Trial. No abstract available.

9

Passive-active immunisation against hepatitis B: immunogenicity studies in adult Americans.

Szmuness W, Stevens CE, Oleszko WR, Goodman A. Szmuness W, et al. Lancet. 1981 Mar 14;1(8220 Pt 1):575-7. doi: 10.1016/s0140-6736(81)92030-4. Lancet. 1981. PMID: 6110818 Clinical Trial.

10

Hepatitis B vaccine: immune responses in haemodialysis patients.

Stevens CE, Szmuness W, Goodman AI, Weseley SA, Fotino M. Stevens CE, et al. Among authors: szmuness w. Lancet. 1980 Dec 6;2(8206):1211-3. doi: 10.1016/s0140-6736(80)92477-0. Lancet. 1980. PMID: 6108392 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results